Poly(A)-binding protein (PABP) is a key player in mRNA circularization and translation initiation of polyadenylated mRNAs. It simultaneously binds the 39 poly(A) tail of an mRNA and eukaryotic initiation factor 4G (eIF4G), which forms part of the translation initiation complex assembling at the 59end, thus circularizing the RNA molecule and enhancing translation initiation. Here, we report the binding of PABP to the non-polyadenylated 39end of dengue virus (DENV) RNA. PABP binds the DENV 39 untranslated region (39UTR) internally, upstream of the conserved 39stem-loop near the two dumb-bell structures, and can be displaced by poly(A) RNA. The PABP-specific translation inhibitor PABP-interacting protein 2 (Paip2) interferes with the DENV 39UTR-PABP interaction, and in vitro translation of DENV reporter RNAs in baby hamster kidney cell extracts is inhibited by Paip2 in a dose-dependent manner. Our findings show an expanded translation mechanism for PABP, binding to a viral RNA lacking a terminal poly(A) tail.
Dengue virus (DENV), a mosquito-borne member of the family Flaviviridae, is a major public health problem in tropical and subtropical areas worldwide, causing~50 million cases of dengue fever and~500 000 cases of the potentially fatal dengue haemorrhagic fever/dengue shock syndrome annually (Gibbons & Vaughn, 2002) . The four DENV serotypes (DENV1-4) contain a 10.7 kb positivestranded RNA genome encoding a single polyprotein flanked by a m 7 G-capped,~100 nt 59 untranslated region (UTR) and a longer (~450 nt) 39UTR . Unlike the majority of cellular mRNAs, DENV RNA lacks a poly(A) tail. Instead, the 39UTR contains a terminal 39stem-loop (39SL), which is conserved across all flaviviruses (Brinton et al., 1986; Hahn et al., 1987; Mohan & Padmanabhan, 1991) , and two dumb-bell (DB) structures containing the conserved sequences CS2 and RCS2 (Hahn et al., 1987; Olsthoorn & Bol, 2001 ). The DENV 39SL binds several cellular proteins such as La autoantigen, polypyrimidine-tract-binding protein (De Nova-Ocampo et al., 2002) , eukaryotic elongation factor 1A (Davis et al., 2007) and Y-box-binding protein-1 (Paranjape & Harris, 2007) . The 39UTR plays an important role at the nucleotide level by harbouring two replication elements, the CS and the UAR (Alvarez et al., 2005b; Hahn et al., 1987; You & Padmanabhan, 1999) , which promote 59end-39end RNA-RNA interaction. This 59end-39end RNA-RNA interaction is critical for viral RNA synthesis but appears not to be necessary for DENV translation (Alvarez et al., 2005a; .
The majority of eukaryotic translation is regulated by the termini of cellular mRNAs via RNA-protein association rather than RNA-RNA interactions. The 59m 7 G-cap and the 39 poly(A) tail enhance translation initiation and have a synergistic effect when present on the same molecule (Gallie, 1991) . The cap initiates assembly of eukaryotic initiation factors (eIFs) by binding eIF4E, which, by recruiting eIF4G, triggers the translational cascade. eIF4G further binds the eIF4A helicase and eIF3, which recruits the 43S ribosomal complex to the 59end of the mRNA (Pestova et al., 2007) . eIF4G also binds poly(A)-binding protein (PABP), which simultaneously interacts with the 39 poly(A) tail, causing circularization of the mRNA and enhancement of its translation efficiency (Imataka et al., 1998; Kahvejian et al., 2005; Tarun & Sachs, 1996) . PABP is a~70 kDa protein with four RNA recognition motifs (RRMs) at the N terminus, the first two of which overlap with the eIF4G-binding site (Adam et al., 1986; Burd et al., 1991; Sachs et al., 1986) . The PABP-poly(A) RNA interaction is abrogated by PABP-interacting protein 2 (Paip2), resulting in translation inhibition (Khaleghpour et al., 2001b) . PABP has two Paip2-binding sites, one in the central RRM region and one at the proline-rich C-terminal end, but only the interaction in the RRM region abrogates the PABP-poly(A) interaction (Khaleghpour et al., 2001a) . Paip2 also represses the translation-enhancing effect of PABP by disrupting the PABP-eIF4G interaction (Karim et al., 2006) . Cellular translation initiation is a highly controlled process. Viruses lacking the cap-structure or a poly(A) tail have developed alternative ways to compete with cellular mRNAs for translation factors and to redirect cellular machinery in their favour. For example, among the members of the family Flaviviridae, the hepacivirus hepatitis C virus contains an internal ribosome entry site (IRES) that recruits the 40S ribosomal subunit and eIF3 directly, omitting the need for eIF4E and eIF4G (Pestova et al., 1998) . The enterovirus poliovirus (PV) also contains an IRES (Pelletier & Sonenberg, 1988) , and its 2A protease cleaves eIF4G, shutting off host-cell translation. PV then uses the resulting C-terminal eIF4G fragment to promote cap-independent viral translation (Etchison et al., 1982; Krausslich et al., 1987; Lloyd et al., 1988) . In addition, the 39pentanucleotide consensus sequence of non-polyadenylated rotavirus (Reoviridae) binds the viral NSP3 protein, which binds eIF4G with high affinity and displaces PABP from the eIF4F complex, thus inhibiting host-cell translation and promoting viral translation (Piron et al., 1998; Vende et al., 2000) .
DENV neither shuts down host-cell protein synthesis nor harbours an IRES, but is able to translate well under eIF4E-limited conditions, suggesting a modified requirement for canonical eIFs . We and others have shown that the non-polyadenylated DENV 39UTR enhances viral translation efficiency (Chiu et al., 2005; Holden & Harris, 2004; Holden et al., 2006) . To investigate the possibility of PABP interacting directly with the DENV 39UTR, we first examined in vitro binding by electrophoresis mobility shift assay (EMSA). The complete DENV2 39UTR (451 nt) was cloned downstream of the T7 polymerase promoter and labelled with [a-32 P]ATP by in vitro transcription. The RNA probe was separated on a denaturing polyacrylamide gel and purified by elution, followed by phenol/chloroform extraction and precipitation with 2-propanol. The purified probe was combined with increasing amounts of purified, His-tagged PABP [a kind gift from R. Andino, UC San Francisco, USA (Herold & Andino, 2001) ] in binding buffer [5 mM HEPES, 25 mM KCl, 2 mM MgCl 2 , 3.8 % glycerol (v/v), 20 mM DTT and 0.2 U SUPERaseIn (Ambion) ml 21 ], supplemented with 1 mg tRNA ml 21 to reduce non-specific binding. Samples were incubated for 10 min at room temperature and then separated on a 4.5 % native polyacrylamide gel at 8 uC (Fig. 1a, left panel) . A shift was readily detected when the 39UTR was incubated with PABP, whereas incubation with the non-specific protein BSA generated no shift (data not shown). The DENV 39UTR-PABP interaction was further characterized by incubating increasing amounts of PABP with a fixed amount of labelled DENV 39UTR under the conditions described above. The complexes were analysed for binding efficiency by slotblot and visualized by phosphorimaging (Typhoon2400, ImageQuant; GE Healthcare), generating a K d of 0.8 mM (Fig. 1b) (Fig. 1a, right panel) , even at the highest concentrations that generated a clear shift with the complete 39UTR (Fig. 1a, left panel) . This implies that PABP binds DENV internally upstream of the 39SL. To confirm this, we examined the 39UTR-PABP interaction by competing with unlabelled 39UTR, 39SL or 39UTR lacking the 39SL (39DSL) (Fig. 1c) . The 39UTR-PABP binding was unaffected even by a 25-fold molar excess of 39SL, but as expected, the interaction was disrupted with equal efficiency by the 39DSL and the control 39UTR (Fig. 1d,  upper panel) . The negative control for non-specific binding, tRNA, had no effect on the 39UTR-PABP complex (data not shown). To narrow down further the PABP-binding region, competition EMSA experiments were performed with 39UTR constructs containing a deletion of DB1, DB2 or both, as well as with a construct containing both DB regions and the A-rich stretches on either side (Fig. 1c) . All three DB deletion mutants still contained the A-rich sequences flanking the DB region. The four constructs competed effectively with the labelled WT-39UTR probe for PABP binding (Fig. 1d, bottom  panel) . The fact that all three DB deletion mutants as well as the DB1+2 construct competed with the WT-39UTR probe for PABP binding and that the only common sequences found in these four constructs were the A-rich regions flanking the DBs suggests that these A-rich regions are likely to be involved in PABP binding.
To validate the specificity of the DENV 39UTR-PABP interaction, the canonical RNA target of PABP, poly(A) RNA, was also used as a competitor (Baer & Kornberg, 1983) . Addition of poly(A) RNA (average length 423 nt; GE Healthcare) to the DENV 39UTR RNA-PABP EMSA mixture disrupted the DENV-PABP interaction in a dosedependent manner, confirming the specificity of the RNAprotein interaction (Fig. 2a) . The dissociation of the 39UTR-PABP complex caused by small increases in the amount of poly(A) RNA is likely due to the multiple PABP-binding sites present on the poly(A) RNA.
To characterize further the nature of the 39UTR-PABP interaction, two PABP-specific antibodies were used to supershift the complex observed by EMSA: anti-PABP N terminus (a-PABP-N; Cell Signaling Technology) and anti-PABP C terminus (a-PABP-C; Abcam PLC) antibodies. DENV 39UTR was incubated in the presence of PABP (see above) with two different concentrations of either antibody. A supershift was observed with the anti-PABP-C but not with the anti-PABP-N antibody, the latter of which may even have slightly inhibited the PABP-39UTR interaction (Fig. 2b) . It is possible that the DENV 39UTR and the anti-PABP-N antibody compete for the same site on PABP. Overall, the supershift observed with anti-PABP-C antibody confirms the 39UTR-PABP interaction.
PABP has been directly implicated in enhancing translation of viral mRNAs. Bradrick et al. (2007) showed that viruses with different IRES exhibit differential requirements for PABP. The more dependent translation from polyadenylated IRES-containing constructs was on the presence of the poly(A) tail and PABP binding, the more sensitive it was to suppression of translation by Paip2. We therefore investigated the effect of Paip2 by using purified Paip2-glutathione S-transferase (GST) to interrupt the DENV 39UTR-PABP interaction. The Paip2-GST expression plasmid was kindly provided by S. Bradrick (Duke University, USA) and Paip2-GST was purified as described previously (Bradrick et al., 2007) . Increasing amounts of Paip2 were added to a constant amount of DENV 39UTR probe and PABP. Low amounts of Paip2 did not interfere with the PABP-39UTR interaction (Fig. 3a, lanes 3-6) , but at higher concentrations (.69 nM) Paip2 disrupted the PABP-39UTR complex and the 39UTR-PAPB shift disappeared (Fig. 3a, lanes 7-8) , which was likely replaced by the PABP-Paip2 interaction. We speculate that the weak, higher-mobility shift shown in lanes 7 and 8 could represent a DENV 39UTR-PABP-Paip2 complex, where Paip2 is bound to the C-terminal end of PABP, which is still bound to the DENV RNA via the N-terminal RRM site. Paip2 does not interact with DENV 39UTR alone, as no shift was detected in the absence of PABP even with the highest Paip2 concentration used (Fig. 3a, lane 9) .
The disruption of DENV 39UTR-PABP interaction by Paip2 indicates that PABP may regulate DENV translation and cellular translation in a similar manner. We previously developed an in vitro translation assay using baby hamster kidney (BHK) cell extract [cells lysed in 100 mM HEPES pH 7.5, 120 mM KOAc, 2.5 mM MgOAc, 100 mM sucrose, 1 mM DTT and 11 % glycerol (v/v), supplemented with 1 mM PMSF, 10 mM leupeptin and 0.2 mM aprotinin], where translation from DENV luciferase reporter RNAs can be assessed (Edgil et al., 2003) . Here, we used a m 7 G-capped DENV reporter RNA containing the DENV2 The DENV 39UTR-PABP complex can be supershifted in EMSA with antibody against the PABP-C terminus ('PABP+Ab+Probe') but not the PABP-N terminus. Anti-PABP-C antibody was assayed at 25 and 125 mg ml "1 and anti-PABP-N antibody at 12.5 and 62.5 mg ml "1 . Despite the addition of an RNase inhibitor, minor probe degradation is nevertheless noticeable upon addition of higher amounts of anti-PABP-C antibody.
59UTR followed by the first 72 nt of the viral capsid gene fused to the firefly luciferase gene and the DENV2 39UTR to provide all the necessary elements for DENV translation (Fig. 3b, top) . Increasing amounts of Paip2 added to the BHK extract inhibited translation of the DENV luciferase reporter in a dose-dependent manner (Fig. 3c) , confirming the importance of PABP in DENV translation. A b-globin reporter RNA containing the 59UTR of b-globin, followed by the firefly luciferase gene and a poly(A) tail (Fig. 3b , bottom) was used as a positive control for translation inhibition by Paip2 (Fig. 3c) .
Here, we have demonstrated the biochemical affinity of PABP for the DENV 39UTR. The specific interaction occurs upstream of the 39SL, likely involving the A-rich sequences that flank the two DB structures. To the best of our knowledge, no other viruses or mRNAs lacking a poly(A) tail have been reported to use PABP to enhance translation. Thus, this interaction is distinct from the 39-terminal poly(A) interaction typical of cellular and some viral mRNAs, but can nonetheless be interrupted by poly(A) RNA. The affinity of PABP binding to the DENV 39UTR and to a poly(A) tail was not directly compared in this study, but the latter has been determined previously and appears to have a higher affinity than that of the PABP-DENV 39UTR interaction (Görlach et al., 1994; Sladic et al., 2004) . Addition of the cellular translation inhibitor and PABP-binding partner Paip2 disrupted the PABP-DENV 39UTR interaction as assessed by EMSA and also inhibited translation of DENV reporter RNAs as well as a b-globin reporter control RNA in vitro. Thus, PABP could serve as the bridging factor for circularization of DENV RNA and translation enhancement, as DENV appears to require eIF4G (C. Polacek & E. Harris, unpublished results). Overall, our data suggest that PABP is a universal translation factor that plays a role in DENV translation machinery despite the lack of viral poly(A) tail. 
